Most blood cancers grow aggressively. But some variants of blood cancers start slowly but are far more dangerous. Myeloproliferative neoplasms (MPNs) are a group of rare blood cells that begin gradually in bone marrow and cause an overproduction of blood cells. Because it progresses gradually, its symptoms are mild.
Main types of myeloproliferative neoplasms
Like other variants of blood cancers, MNPs also have their three main types:
Polycythemia leads to excessive production of red blood cells and an increased risk of blood clots.
Essential thrombocythemia increases platelets and causes abnormal blood clotting and bleeding.
Myelofibrosis is more advanced, where the bone marrow disrupts the normal blood cell production.
Early symptoms that you should know
The symptoms of MNPs are too subtle to notice when we are busy with our normal routine. In many cases, they are easily overlooked and mistaken for something absolutely normal.
You may experience persistent fatigue, which is caused by abnormal blood cell production.
You may also face unexplained nosebleeds or sudden blood clots, which were previously not common.
Swelling of the spleen may occur due to excess blood cell filtering, which leads to abdominal fullness.
What are the potential risks of MNPs
MNPs are generally slow-growing cancers, but they also have long-term effects on your health. The overproduction of your blood cells may increase the risk of blood clots, which might cause strokes or other cardiovascular issues. In cases of myelofibrosis, bone marrow scarring may impair your normal blood cell production, and you end up feeling constant fatigue. Sometimes, it may also increase the risk of leukemia progression, which is an aggressive blood cancer. With these existing risks, timely medical care and proper monitoring become even more important.
Treatment options for MNPs
The primary focus of treatment for MNPs is to control your symptoms and slow down their progression. If you detect the disease early, then careful monitoring along with blood tests is enough. The medications are used for blood count management, lowering blood clot risks, and symptom relief. In many cases, targeted therapy may also be the best option, as it acts on a specific gene mutation to regulate abnormal cell production more accurately.
Managing a long-term diagnosis
It's difficult to detect MNPs with such subtle signs and slow growth. It’s normal if you get confused at such times. But staying aware and having an open conversation with your doctors can give you clarity. With the right care, you will eventually gain control of your health, which will help you to heal better.